首頁 > 市場調查報告書 > 食物/飲料

機能性食品

北美維生素 K2 市場預測至 2030 年 - 區域分析 - 按產品、劑型、來源和應用

市場調查報告書

商品編碼

1481993

北美維生素 K2 市場預測至 2030 年 - 區域分析 - 按產品、劑型、來源和應用

North America Vitamin K2 Market Forecast to 2030 - Regional Analysis - by Product, Dosage Forms, Source, and Application

出版日期: 2024年03月04日 | 出版商:

The Insight Partners | 英文 81 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

北美維生素K2市場預計將從2022年的6,389萬美元成長到2030年的4.9,438億美元。

CVD 的日益普及推動了北美維生素 K2 市場

心血管疾病（CVD）仍然是一個重大的全球健康問題，近年來其盛行率穩定上升。這種上升是由於人口老化、久坐的生活方式和不良的飲食選擇，以及糖尿病、高膽固醇血症和高血壓等危險因子的日益普及。據世界衛生組織稱，CVD 是死亡的主要原因，全球每年約有 1,790 萬人因此死亡。

研究人員正在探索各種預防和治療方法來對抗心血管疾病。人們感興趣的領域之一是維生素 K2 在心血管健康中的潛在作用。維生素 K2 或甲基萘醌是維生素 K 的一種形式，與潛在的心血管益處有關。維生素 K2 影響心血管健康的關鍵機制是其調節鈣代謝的作用。動脈鈣化是鈣沉積在動脈壁中積聚的過程，會導致動脈粥狀硬化的發展，而動脈粥狀硬化是心血管疾病的一個主要根本原因。研究發現，維生素 K2 透過活化有助於調節鈣沉積的蛋白質，在抑制動脈鈣化方面發揮重要作用，從而降低動脈粥狀硬化和相關心血管疾病的風險。

幾項觀察性研究探討了維生素 K2 攝取量與 CVD 結局之間的潛在關聯。雖然這些研究無法建立明確的因果關係，但它們提供了有趣的見解。《營養雜誌》的一項研究發現，較高的維生素 K2 攝取量與較低的冠心病死亡率風險有關。此外，維生素 K2 應被視為與生活方式改變一起的潛在輔助治療或預防措施。這些改變包括採用富含水果、全穀類、蔬菜和瘦蛋白的均衡飲食；保持健康的體重；定期進行體力活動；管理血壓和膽固醇水平；以及戒掉吸菸的習慣。因此，CVD 的日益普及正在推動北美維生素 K2 市場的發展。

北美維生素 K2 市場概況

北美維生素 K2 市場分為美國、加拿大和墨西哥。市場的成長歸因於心血管疾病盛行率的增加以及成人和新生兒骨質疏鬆症骨變形病例的增加。然而，人們對維生素 K2 益處的認知有限，阻礙了市場的成長。北美市場的成長也歸因於維生素 K2 營養補充劑的日益普及。美國佔據北美維生素 K2 市場的最大佔有率。心血管疾病和骨質疏鬆症和關節炎等骨科疾病的盛行率不斷增加，增加了對維生素K2 的需求，因為它有助於更好地吸收鈣和其他營養物質，並增強心臟和骨骼健康。根據美國疾病管制與預防中心 (CDC) 的數據，2021 年，美國約有 695,000 人死於心臟病，其中冠心病是最常見的心臟病類型，導致該國 375,476 人死亡。此外，該國正在進行產品發布、收購和合併等各種策略發展，也促進了市場的成長。 2022年10月，Kappa Bioscience在美國市場推出了首款有機級維生素K2-MK7，品牌名為K2Vital。它是美國市場上第一個經美國農業部 (USDA) 有機認證的全反式、全生物活性維生素 K2-MK7，用於油性健康應用。因此，心血管疾病和骨科疾病盛行率的上升以及策略合作的增加預計將推動美國維生素 K2 市場的成長。

北美維生素 K2 市場收入及 2030 年預測（百萬美元）

北美維生素 K2 市場區隔

北美維生素 K2 市場按產品、劑型、來源、應用和國家細分。

根據產品，北美維生素 K2 市場分為 MK-4、MK-7 和組合藥物。 2022 年，MK-7 細分市場佔據北美維生素 K2 市場的最大佔有率。

根據劑型，北美維生素 K2 市場分為膠囊和片劑、粉末和油。 2022 年，粉末細分市場佔據北美維生素 K2 市場的最大佔有率。

根據來源，北美維生素 K2 市場分為天然維生素 K2 和合成維生素 K2。 2022 年，天然維生素 K2 在北美維生素 K2 市場中佔據更大佔有率。

根據應用，北美維生素 K2 市場分為藥品、營養保健品和食品等。 2022 年，藥品領域佔據北美維生素 K2 市場的最大佔有率。

根據國家/地區，北美維生素 K2 市場分為美國、加拿大和墨西哥。 2022 年，美國將主導北美維生素 K2 市場。

Anderson Global Group LLC、Balchem Corp、BASF SE、Glanbia Plc、International Flavors & Fragrances Inc、Koninklijke DSM NV、Lesaffre et Cie SA、Lonza Group AG 和 Novozymes AS 是北美維生素 K2 市場上的一些領先公司。

Cardiovascular disease (CVD) continues to be a significant global health concern, with its prevalence steadily increasing in recent years. This rise is due to the aging population, sedentary lifestyles, and poor dietary choices, along with the growing prevalence of risk factors, including diabetes, hypercholesterolemia, and hypertension. According to World Health Organization, CVD is a leading cause of death with ~17.9 million deaths every year globally.

Researchers are exploring various preventive and therapeutic approaches to combat CVD. One area of interest is the potential role of vitamin K2 in cardiovascular health. Vitamin K2, or menaquinone, is a form of vitamin K linked to potential cardiovascular benefits. A critical mechanism by which vitamin K2 impacts cardiovascular health is its role in regulating calcium metabolism. Arterial calcification, the process of calcium deposits accumulating in the arterial walls, contributes to the development of atherosclerosis, a major underlying cause of CVD. Vitamin K2 has been found to play a significant role in inhibiting arterial calcification by activating proteins that help regulate calcium deposition, thus reducing the risk of atherosclerosis and related cardiovascular disorders.

Several observational studies have examined the potential association between vitamin K2 intake and CVD outcomes. While these studies are unable to establish a definitive cause-and-effect relationship, they have provided interesting insights. A study by the Journal of Nutrition found that higher vitamin K2 intake was linked to a lower risk of coronary heart disease mortality. Further, vitamin K2 should be considered a potential adjunctive therapy or preventive measure alongside lifestyle changes. These modifications include adopting a balanced diet rich in fruits, whole grains, vegetables, and lean proteins; maintaining a healthy weight; engaging in regular physical activity; managing blood pressure and cholesterol levels; and stopping smoking habits. Thus, the increasing prevalence of CVD is driving the North America vitamin K2 market.

North America Vitamin K2 Market Overview

The North America Vitamin K2 market is segmented into the US, Canada, and Mexico. The growth of the market is attributed to the increasing prevalence of CVD and growing cases of osteoporosis bone deformation in adults and newborns. However, the limited awareness regarding benefits of vitamin K2 hinders the market growth. The market growth in North America is also attributed to the rising adoption of nutraceutical supplements for vitamin K2. The US accounts for the largest share of the vitamin K2 market in North America. The increasing prevalence of cardiovascular diseases and orthopedic disorders, such as osteoporosis and arthritis, has increased the demand for vitamin K2, as it helps in the better absorption of calcium and other nutrients, strengthening cardiac and bone health. According to the Centers for Disease Control and Prevention (CDC), in 2021, ~695,000 people died from heart disease in the US, coronary heart disease being the most common type of heart disease that resulted in the death of 375,476 people in the country. Moreover, various strategic developments such as product launches, acquisitions, and mergers have been taking place in the country, which are contributing to the market growth. In October 2022, Kappa Bioscience launched its first organic grade vitamin K2-MK7 in the US market under the brand name K2Vital. It is the first US Department of Agriculture (USDA) organic-certified all-trans, all-bioactive vitamin K2-MK7 for oil-based health applications in the US market. Therefore, the rising prevalence of cardiovascular diseases and orthopedic disorders, along with an increase in strategic collaboration, is expected to drive the vitamin K2 market growth in the US.

North America Vitamin K2 Market Revenue and Forecast to 2030 (US$ Million)

North America Vitamin K2 Market Segmentation

The North America vitamin K2 market is segmented into product, dosage forms, source, application, and country.

Based on product, the North America vitamin K2 market is segmented into MK-4, MK-7, and combination drugs. The MK-7 segment held the largest share of the North America vitamin K2 market in 2022.

Based on dosage forms, the North America vitamin K2 market is segmented into capsules & tablets, powder, and oils. The powder segment held the largest share of the North America vitamin K2 market in 2022.

Based on source, the North America vitamin K2 market is segmented into natural and synthetic. The natural segment held a larger share of the North America vitamin K2 market in 2022.

Based on application, the North America vitamin K2 market is segmented into pharmaceuticals, nutraceuticals and food, and others. The pharmaceuticals segment held the largest share of the North America vitamin K2 market in 2022.

Based on country, the North America vitamin K2 market is segmented into the US, Canada, and Mexico. The US dominated the North America vitamin K2 market in 2022.

Anderson Global Group LLC, Balchem Corp, BASF SE, Glanbia Plc, International Flavors & Fragrances Inc, Koninklijke DSM NV, Lesaffre et Cie SA, Lonza Group AG, and Novozymes AS are some of the leading companies operating in the North America vitamin K2 market.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. North America Vitamin K2 Market - Key Industry Dynamics

4.1 Key Market Drivers:
- 4.1.1 Increasing Prevalence of CVD
- 4.1.2 Growing Cases of Osteoporosis Bone Deformation in Adults and Newborns
4.2 Market Restraints
- 4.2.1 Limited Awareness Regarding Benefits of Vitamin K2
4.3 Market Opportunities
- 4.3.1 Expansion of Distribution Channel
4.4 Future Trends
- 4.4.1 Regulatory Consideration and Standards
4.5 Impact Analysis:

5. Vitamin K2 Market - North America Market Analysis

5.1 North America Vitamin K2 Market Revenue (US$ Mn), 2022 - 2030

6. North America Vitamin K2 Market - Revenue and Forecast to 2030 - by Product.

6.1 Overview
6.2 North America Vitamin K2 Market Revenue Share, by Product 2022 & 2030 (%)
6.3 MK-4
- 6.3.1 Overview
- 6.3.2 MK-4: North America Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
6.4 MK-7
- 6.4.1 Overview
- 6.4.2 MK-7: North America Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
6.5 Combination Drugs
- 6.5.1 Overview
- 6.5.2 Combination Drugs: North America Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)

7. North America Vitamin K2 Market - Revenue and Forecast to 2030 - by Dosage Form.

7.1 Overview
7.2 North America Vitamin K2 Market Revenue Share, by Dosage Form, 2022 & 2030 (%)
7.3 Capsules and Tablets
- 7.3.1 Overview
- 7.3.2 Capsules and Tablets: North America Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Powder
- 7.4.1 Overview
- 7.4.2 Powder: North America Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Oil
- 7.5.1 Overview
- 7.5.2 Oil: North America Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)

8. North America Vitamin K2 Market - Revenue and Forecast to 2030 - by Source.

8.1 Overview
8.2 North America Vitamin K2 Market Revenue Share, by Source, 2022 & 2030 (%)
8.3 Natural
- 8.3.1 Overview
- 8.3.2 Natural: North America Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Synthetic
- 8.4.1 Overview
- 8.4.2 Synthetic: North America Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)

9. North America Vitamin K2 Market - Revenue and Forecast to 2030 - by Application.

9.1 Overview
9.2 North America Vitamin K2 Market Revenue Share, by Application, 2022 & 2030 (%)
9.3 Pharmaceuticals
- 9.3.1 Overview
- 9.3.2 Pharmaceuticals: North America Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Nutraceuticals and Food
- 9.4.1 Overview
- 9.4.2 Nutraceuticals and Food: North America Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
9.5 Others
- 9.5.1 Overview
- 9.5.2 Others: North America Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)

10. North America Vitamin K2 Market - Country Analysis

10.1.1 North America, by Country, 2022 & 2030 (%)
- 10.1.1.1 US: North America Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
  - 10.1.1.1.1 Overview
  - 10.1.1.1.2 US: North America Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
  - 10.1.1.1.3 US: North America Vitamin K2 Market, by Product, 2020-2030 (US$ Million)
  - 10.1.1.1.4 US: North America Vitamin K2 Market, by Dosage Form, 2020-2030 (US$ Million)
  - 10.1.1.1.5 US: North America Vitamin K2 Market, by Source, 2020-2030 (US$ Million)
  - 10.1.1.1.6 US: North America Vitamin K2 Market, by Application, 2020-2030 (US$ Million)
- 10.1.1.2 Canada: North America Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
  - 10.1.1.2.1 Overview
  - 10.1.1.2.2 Canada: North America Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
  - 10.1.1.2.3 Canada: North America Vitamin K2 Market, by Product, 2020-2030 (US$ Million)
  - 10.1.1.2.4 Canada: North America Vitamin K2 Market, by Dosage Form, 2020-2030 (US$ Million)
  - 10.1.1.2.5 Canada: North America Vitamin K2 Market, by Source, 2020-2030 (US$ Million)
  - 10.1.1.2.6 Canada: North America Vitamin K2 Market, by Application, 2020-2030 (US$ Million)
- 10.1.1.3 Mexico: North America Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
  - 10.1.1.3.1 Overview
  - 10.1.1.3.2 Mexico: North America Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
  - 10.1.1.3.3 Mexico: North America Vitamin K2 Market, by Product, 2020-2030 (US$ Million)
  - 10.1.1.3.4 Mexico: North America Vitamin K2 Market, by Dosage Form, 2020-2030 (US$ Million)
  - 10.1.1.3.5 Mexico: North America Vitamin K2 Market, by Source, 2020-2030 (US$ Million)
  - 10.1.1.3.6 Mexico: North America Vitamin K2 Market, by Application, 2020-2030 (US$ Million)

11. Vitamin K2 Market Industry Landscape

11.1 Overview
11.2 Growth Strategies in Vitamin K2 Market
11.3 Organic Growth Strategies
- 11.3.1 Overview
11.4 Inorganic Growth Strategies
- 11.4.1 Overview

12. Company Profiles

12.1 Lonza Group AG
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 International Flavors & Fragrances Inc
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Balchem Corp
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 BASF SE
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Lesaffre et Cie SA
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Koninklijke DSM NV
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Novozymes AS
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 Glanbia Plc
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Anderson Global Group LLC
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments

13. Appendix

13.1 About Us
13.2 Glossary of Terms

簡介目錄圖表

List Of Tables

Table 1. North America Vitamin K2 Market Segmentation
Table 2. US: North America Vitamin K2 Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 3. US: North America Vitamin K2 Market, by Dosage Form- Revenue and Forecast to 2030 (US$ Million)
Table 4. US: North America Vitamin K2 Market, by Source- Revenue and Forecast to 2030 (US$ Million)
Table 5. US: North America Vitamin K2 Market, by Application- Revenue and Forecast to 2030 (US$ Million)
Table 6. Canada: North America Vitamin K2 Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 7. Canada: North America Vitamin K2 Market, by Dosage Form- Revenue and Forecast to 2030 (US$ Million)
Table 8. Canada: North America Vitamin K2 Market, by Source- Revenue and Forecast to 2030 (US$ Million)
Table 9. Canada: North America Vitamin K2 Market, by Application- Revenue and Forecast to 2030 (US$ Million)
Table 10. Mexico: North America Vitamin K2 Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 11. Mexico: North America Vitamin K2 Market, by Dosage Form- Revenue and Forecast to 2030 (US$ Million)
Table 12. Mexico: North America Vitamin K2 Market, by Source- Revenue and Forecast to 2030 (US$ Million)
Table 13. Mexico: North America Vitamin K2 Market, by Application- Revenue and Forecast to 2030 (US$ Million)
Table 14. Recent Organic Growth Strategies in Vitamin K2 Market
Table 15. Recent Inorganic Growth Strategies in the Vitamin K2 Market
Table 16. Glossary of Terms, North America Vitamin K2 Market

List Of Figures

Figure 1. North America Vitamin K2 Market Segmentation, By Country
Figure 2. North America Vitamin K2 Market - Key Industry Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. North America Vitamin K2 Market Revenue (US$ Mn), 2022 - 2030
Figure 5. North America Vitamin K2 Market Revenue Share, by Product 2022 & 2030 (%)
Figure 6. MK-4: North America Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. MK-7: North America Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Combination Drugs: North America Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. North America Vitamin K2 Market Revenue Share, by Dosage Form 2022 & 2030 (%)
Figure 10. Capsules and Tablets: North America Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Powder: North America Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Oil: North America Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. North America Vitamin K2 Market Revenue Share, by Source 2022 & 2030 (%)
Figure 14. Natural: North America Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Synthetic: North America Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. North America Vitamin K2 Market Revenue Share, by Application 2022 & 2030 (%)
Figure 17. Pharmaceuticals: North America Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Nutraceuticals and Food: North America Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. Others: North America Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
Figure 20. North America Vitamin K2 Market, by Key Country - Revenue (2022) (US$ Million)
Figure 21. North America, by Country, 2022 & 2030 (%)
Figure 22. US: North America Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. Canada: North America Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
Figure 24. Mexico: North America Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
Figure 25. Growth Strategies in Vitamin K2 Market